Molecular Templates Inc reports results for the quarter ended in December - Earnings Summary

Molecular Templates

29/03/2024 13:10

* Molecular Templates Inc  MTEM.OQ  reported a quarterly
adjusted
loss of 73 cents​​ per share for the quarter ended in December,
higher than the same quarter last year, when the company
reported EPS of $-5.87.  The mean expectation of two analysts
for the quarter was for a loss of 97 cents per share. 
    * Revenue rose 168.7% to $7.02 million from a year ago;
analysts
expected $7.78 million. 
    * Molecular Templates Inc's reported EPS for the quarter was
a
loss of 73 cents​.
    * The company reported a quarterly loss of $3.95 million.
    * Molecular Templates Inc shares had fallen by 36.7% this
quarter.

FORECAST CHANGES
    * The mean earnings estimate of analysts was unchanged in
the last
three months.​ 
    * In the last 30 days, there have been no earnings estimate
revisions by analysts covering the company.

RECOMMENDATIONS
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 1 "strong buy" or "buy," no
"hold" and no "sell" or "strong sell." 
    * The average consensus recommendation for the biotechnology
&
medical research peer group is also "buy"

Wall Street's median 12-month price target for Molecular
Templates Inc is $16.50 
This summary was machine generated from LSEG data March 29 at
01:10 p.m. UTC. ​All figures in US dollars unless otherwise
stated. (For questions concerning the data in this report,
contact Estimates.Support@lseg.com. For any other questions or
feedback, contact RefinitivNewsSupport@thomsonreuters.com) QUARTER ENDING    ESTIMATE       ACTUAL         BEAT, MET,
                                                 MISSED
 Dec. 31 2023      -0.97          -0.73          Beat
 Sep. 30 2023      -1.39          -0.82          Beat
 Jun. 30 2023      -5.17          -2.85          Beat
 Mar. 31 2023      -4.20          2.85           Beat